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Abstract 
Progress in genome research led to new perspectives in diagnostic applications and to new 
promising therapies. On account of their specificity and sensitivity, nucleic acids (DNA/RNA) 
increasingly are in the focus of the scientific interest. While nucleic acids were a target of 
therapeutic interventions up to now, they could serve as excellent tools in the future, being 
highly sequence-specific in molecular diagnostics. Examples for imaging modalities are the 
representation of metabolic processes (Molecular Imaging) and customized therapeutic ap-
proaches (“Targeted Therapy”). In the individualized medicine nucleic acids could play a key 
role; this requires new properties of the nucleic acids, such as stability. Due to evolutionary 
reasons natural nucleic acids are substrates for nucleases and therefore suitable only to a 
limited extent as a drug. To use DNA as an excellent drug, modifications are required leading 
e.g. to a peptide nucleic acid (PNA). Here we show that an easy substitution of nucleobases by 
functional molecules with different reactivity like the Reppe anhydride and pentenoic acid 
derivatives is feasible. These derivatives allow an independent multi-ligation of functionalized 
compounds, e.g. pharmacologically active ones together with imaging components, leading to 
local concentrations sufficient for therapy and diagnostics at the same time. The high chemical 
stability and ease of synthesis could enhance nucleic chemistry applications and qualify PNA as 
a favourite for delivery. This system is not restricted to medicament material, but appropriate 
for the development of new and highly efficient drugs for a sustainable pharmacy. 
Key words: Click Chemistry; Diels Alder Reactioninvers (DARinv); Peptide Nucleic Acid (PNA); PNA 
building block functionalization 
Introduction 
Open questions in the world of nucleic acids are 
areas for improvement of the hypotheses concerning 
the origin of the life and the crucial genetic building 
blocks. The search for simpler precursor molecules 
leads to the peptide nucleic acid world (PNA).[1-3] At 
present PNA finds increasing interest in the scientific 
community. This manuscript does not intend to an-
swer questions concerning the greater plausibility of 
PNA world as compared to the RNA/DNA world, 
but shows that PNA is an excellent biochemical tool in Int. J. Med. Sci. 2010, 7 
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the ligation chemistry. Qualified ligation reactions, 
like the Huisgens’s 1,3-dipolar cycloaddition [4], the 
Staudinger ligation refined by Bertozzi using a 
chemical reaction of phoshines with azides [5] and the 
established thio-ester-method [6] fulfil almost criteria 
of the term “Click Chemistry” introduced by Shar-
pless and which can be considered as a chemical phi-
losophy.[7] As described by Finn and Fokin: the 
‘‘Click’’ moniker is meant to signify that by use of 
these ligation methods. Joining molecular pieces is as 
easy as ‘‘clicking’’ together the two pieces of a 
buckle.[8] Some attributes of this philosophy are ap-
plicable to the broad spectrum of the general Diels 
Alder Reaction (DAR). Their potential and the syn-
thesis’ mechanisms as well as its characteristic phys-
ico-chemical traits are well documented and traced 
back to 1948.[9-11] In contrast, the DAR with in-
verse-electron-demand (DARinv) was described al-
most 10 years later.[12-15] Its chemical properties 
(rapid reaction rate, complete chemical reaction, lack 
of reverse reaction, chemical reaction in aqueous so-
lution, under room temperature, no need for a cata-
lyst) predetermines the DARinv as a suitable Click 
Chemistry-technology in cellular systems for intravi-
tal ligation of components. With respect to reaching 
high local concentrations of diagnostics in cells for 
molecular imaging and specific therapeutically active 
molecules, PNAs are powerful tools providing a 
multi-faced range of biochemical applications.[16-18] 
Similar to DNA derivatives like phosphothioates, 
phosphoramidates, 2’-O-alkyl- 
DNAs, morpholino and bicyclically locked nucleic 
acid derivatives (LNA), PNA mimics the DNA and 
RNA compositions and matches with nucleic acids 
under Watson-Crick hydrogen-bond formation. 
[19-24] Whereas the DNA derivatives still harbour the 
nucleic acid skeletal structure and possess the original 
stereochemical features resulting in a different affinity 
and specificity behaviour, the PNA is a substantially 
derivatized molecule. In PNA the phospho-ribose 
backbone is substituted with N-(2-amino-ethyl)- 
glycine units connected to an ethylene-diamine linker. 
Only the distance of the nucleobases remains con-
served and corresponds to the nucleic acids’ nucleo-
bases interspace. The physico-chemical properties 
specific to PNA are based on its typical molecular 
structure: PNA mimics DNA through a 
pseudo-peptide backbone.[25] PNA is neither a nu-
cleic acid nor a peptide and therefore not a substrate 
for nucleases and peptidases.[26] Furthermore the 
lack of asymmetric centers results in a higher affin-
ity.[27] In this context, the PNA represents a new class 
of efficient tools for molecular diagnosis, chromoso-
mal investigations, molecular genetics and cytoge-
netics, antisense and antigenic agents, and for transfer 
of genetic material into target cells as reversible cou-
pling molecules.[28]  
The main drawback however is based in other 
PNA specific properties: The lack of electrical charge 
and therefore much higher hydrophobicity leads to 
insolubility and self-aggregation of chains of more 
than 14mers in water, which results in a poor cellular 
uptake into cells and restricts the applications.[29]  
To circumvent these drawbacks and to improve 
the local intracellular PNA concentrations manifold 
different approaches were considered: like: transfec-
tion technologies, virally-[30] and non-virally [31-33] 
mediated uptake procedures, lipofection [34], lipo-
some[35], electroporation and ultrasound[36] medi-
ated methods, gene gun etc.[37] We preferred the 
coupling of such a PNA cargo to carrier molecules 
which is possible with variable chemistry: (I) either in 
a cleavable form by a reversible disulfide bridge bond 
or (II) by non-cleavable covalent bonds and a (III) by 
hydrogen bridge formation. The main problems in 
coupling these molecules turned out to be the slow 
reaction rates and the incomplete chemical ligation 
reactions, as well as their reverse reactions, which all 
were improved in this publication. A further restric-
tion lies in the insufficient amounts of active sub-
stances at the reaction site. Our approach circumvents 
this by synthesis of PNA polymers through PNA 
pentamers. Both, the proper and rapid DARinv medi-
ated ligation and the easy design of PNA polymers 
can meet demands on modern drugs and diagnostic 
molecules. 
Chemical Procedures 
Monomer Synthesis 
Functionalization of PNA backbone building blocks 
The synthesis of functionalized PNA for the 
DARinv was carried out as depicted in the steps de-
scribed here. To circumvent the above mentioned 
problems the development of suitable reactants is 
essential. The generally accepted syntheses of the de-
sired PNA building blocks are shown in the following 
schemata and are documented in detail by the 
Thomson group.[38] The synthesis begins with the 
synthesis of 5 a Reppe anhydride PNA derivative 
based on the educts cyclooctatetraene (COT) 1 and 
maleic acid anhydride 2 as described by Reppe [39] is 
shown in scheme 1 (Figure 1).  
 Int. J. Med. Sci. 2010, 7 
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Figure 1.  (Scheme  1)  illustrates the steps for synthesis of a nucleobase–substituent, with tetracy-
clo-[5.4.2
1,7.O
2,6.O
8,11]3,5-dioxo-4-aza-9,12-tridecadiene (TcT) as an example (documented as “Reppe anhydride”). The 
chemical reaction is described in detail by Reppe.[39] The reaction product of 3 with glycine is 4 whose carboxyl group was 
transferred immediately with thionyl chloride to the corresponding acid chloride 5 for further processing as described in 
scheme 3 (Figure 3).  
 
 
Synthesis of the “Reppe anhydride”-PNA building block 
We started with the chemical synthesis of the 
“Reppe anhydride”-PNA building block (tetracy-
clo-[5.4.21,7.O2,6.O8,11]3,5-dioxo-4-aza-9,12-tridecadiene
) 3 as illustrated in scheme 1/Figure 1. 
Synthesis of the PNA building block backbone 
In the next step, the synthesis of the PNA back-
bone monomer using the fluorenylmethoxycarbonyl 
(Fmoc) protection occurred as described by Atherton 
and Sheppard.[40] 
Synthesis of the Fmoc-C2-glycine-tert-butyl ester 
The synthesis of the peptide nucleic acid back-
bone requires the introduction of protecting groups as 
shown in the Fmoc-C2-glycine-tert-butyl ester de-
rivative  9 (scheme 2/Figure 2). A reaction product 
which was converted to the final product 9 is the 
tert-butyl protected 3-[(2-aminoethyl)amino]glycine 8. 
Details of the synthesis protocol are shown in the 
footnote.1 
                                                      
1 tert-butyl 3-[(2-aminoethyl)amino]glycine: Ethylenedia-
mine (0.72 mol) 6 was pre-filled in a 5-fold molar excess in 
40 ml chloroform and kept on ice. Then, with continuous 
stirring, a mixed solution of 20 ml chloroform and 0.144 mol 
chloride acetic acid tert-butyl ester 7 was added over a pe-
riod of 90 minutes. The reaction mix was stirred over night 
at room temperature and then the product 8 was rinsed 
twice with water and desiccated. (The solvent was removed 
with a rotary evaporator.) Fmoc-C2-glycine-tert-butyl es-
ter: The complete reaction product (0.1127 mol) tert-butyl 
3-[(2-aminoethyl)amino]glycine 8 was consecutively used 
for chemical reaction with 0.1127 mol 
N,N-diisopropylethylamine in 500 ml dichloromethane. 
Then 0.1127 mol Fmoc-succinimide dissolved in 200ml di-
chloromethane were added dropwise over a period of 4 
hours. After 1 hour a clouding of the reaction solution and 
separation of a substance could be observed. The reaction 
solution was stirred during the whole weekend and then, 
after rinsing fivefold with 200 ml 1 N HCl and once more 
with saturated solution of sodium chloride, the precipitate 
Coupling of the Fmoc-C2-glycine-tert-butyl ester with 
the Reppe anhydride. 
The next scheme illustrates the chemical reaction 
steps to the complete PNA monomer functionalized 
with the Reppe anhydride called RE-PNA 11 was then 
ready for use in the solide phase PNA synthesis. The 
instructions for synthesis are documented in the 
footnote.2  All steps of the chemical reactions are il-
lustrated in scheme 3/Figure 3. 
                                                                                        
was desiccated. During the concentration of the solution a 
slow-going crystallization was observed. The crystalline 
product Fmoc protected-[(2-aminoethyl)glycine] tert-butyl 
ester 9 was washed manifold with ether and subsequently 
desiccated. 
2 Coupling of the Fmoc-C2-glycine-tert-butyl ester with 
the Reppe anhydride: 2 mmol of the 
Fmoc-C2-glycine-tert-butyl ester 9 and 4 mmol 
N,N-diisopropylethylamine were pre-filled in 10ml di-
chloromethane and consecutively 5 ml dichloromethane 
was added by the dropping funnel stirring constantly over a 
period of 30 minutes. The yellow coloured product was 
concentrated by the rotary evaporator. The residue featur-
ing a glass-like consistency was dissolved in dichlorome-
thane and purified by silica gel column chromatography. 
Chloroform and ethanol were used for elution at a ratio of 
95:5. Cleavage of the tert-butyl group: 2 mmol tert-butyl 
protected Fmoc-PNA building block 10 functionalized with 
5 the glycine acetic chloride derivative of the Reppe anhy-
dride was dissolved in 5 ml dichloromethane and 5 ml trif-
luoroacetic acid (TFA) and simultaneously 5 ml TFA dis-
solved in dichloromethane were added successively by a 
dropping funnel. The reaction batch was stirred continu-
ously over night and the reaction’s completeness was ex-
amined using thin-layer chromatography. The yellow col-
oured product was concentrated by rotary evaporator and 
covered with a layer of ether. The product {scheme 3: 11 
[RE-PNA], scheme 6: 16} precipitates voluminously, de-
pending on the quantity the precipitation process can take 
up to two days. In this case the precipitation should run at a 
temperature of 4°C.  Int. J. Med. Sci. 2010, 7 
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Figure 2.  (Scheme  2)  reports the chemical reaction of the PNA back bone module Fmoc pro-
tected-[(2-aminoethyl)glycine] tert-butyl ester unit 9, which was received by the reaction of ethylenediamine 6 and chloride 
acetic acid-tert-butyl ester 7. The reaction product 8 reacts with Fmoc-succinimide to 9. 
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Figure 3. (Scheme 3)  5 reacts with 9 to the tert-butyl ester of the peptide nucleic acid monomer (Fmoc protected) 10 as 
a reaction product. After hydrolysis of the tert-butyl ester, catalyzed by acid, the peptide nucleic acid monomer (Fmoc 
protected) was functionalized with the Reppe anhydride 11 referred to as RE-PNA in the text. According the scheme 3  the 
synthesis consists of two procedures carried out as described in detail in the footnote 2. 
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Figure 4. (Scheme 4):  exemplifies  the  chemical structure of the pentamer consisting of the “Reppe anhydride” 
[(RE-PNA)5Cys]. The amino terminus of the PNA backbone possesses a cysteine which acts as a Redox coupling site. 
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Figure 5. (Scheme 5):  shows the pentamer of the “Reppe anhydride” [(RE-PNA)5Cys] connected by the cysteine mediated 
disulfide formation with the CPP-Cys (displayed in amino acid single letter code). The ligation procedure of the two 
components by disulfide-bridge formation is documented [43]. 
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Synthesis of the 4-pentenoic acid PNA monomer 
To enhance the application spectrum of the 
“Click” chemistry we used as an additional example 
the pentenyl-PNA building block, a further PNA de-
rivative, whose PNA monomer is functionalized with 
a 4-pentenoic acid. Scheme 6 (Figure 6) demonstrates 
our synthesis procedures of functional molecules for 
DAR (X), exemplarily monomers of the 
4-pentenyl-PNA (scheme 7/Figure 7).  
Based on the synthesis protocols as described 
under schemata 1 to 3, the scheme 1 acts as a “hard” 
and fast rule for the synthesis of functional molecules 
suitable for the design of functionalized building 
blocks of PNA or other nucleic acid derivatives. Here 
the component 14 is comparable to number 5 in the 
scheme 3 and can be substituted by a broad spectrum 
of functional molecules according the reasons of re-
search. Examples of functional molecules are listed in 
table 1. 
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Figure 6. (Scheme 6)  exemplifies a commonly applicable 
instruction for synthesis of molecules suitable for func-
tionalization of PNA: Fmoc-C2-glycine-tert-butyl ester 9 
reacts with the carbonic acid chloride of the DAR com-
ponent X 14 to the corresponding tert-butyl ester of the 
peptide nucleic acid monomer (Fmoc protected) 15. After 
hydrolysis of the tert-butyl ester catalyzed by acid, the 
peptide nucleic acid monomer (Fmoc protected) function-
alized with the DAR component X 16 is received.  
Synthesis of the 4-pentenoic acid PNA building block 
The synthesis of the PNA building block func-
tionalized with the 4-pentenoic acid is shown as an 
example for a myriad of applications. The synthesis is 
described in the footnote3  and represents a general 
prescription for the functionalization of PNA. 
                                                      
3 Synthesis of the Fmoc-pentenoic acid-PNA. For synthesis 
of the pentenoic acid PNA (scheme 3), equimolar (2 mmol) 
Glycine and pentenoic acid were transformed. In the 
N-ethylisopropylamine (4 mmol) (Huening’s base) / gly-
cine mix the pentenoic acid chloride dissolved in dichloro-
methane was added in drops over night. 
N C
HN
Fmoc
O
OH
C
O
 
Figure 7.  (Scheme  7) shows the PNA building block 
Fmoc protected and functionalized with 4-pentenoic acid 
17 acting as a dienophile component. According to the 
scheme 6 the synthesis consists of two procedures and was 
carried out as described in the footnote
4. 
This device works in a variety of ligation areas 
which will be described in the following. 
Synthesis of PNA polymers 
Using the solid phase synthesis we obtained 
functional modular PNA oligomers for coupling dif-
ferent active agents and imaging molecules together, 
or just one of those in parallel to reach local concen-
trations unachievable until now. 
                                                                                        
Coupling of the 4-pentenoic acid chloride to the PNA 
backbone building block. 2 mmol 
Fmoc-C2-glycine-tert-butyl ester 9 reacts with 4 mmol 
N,N-diisopropylethylamine dissolved in 10 ml dichloro-
methane. 2 mmol 4-pentenoic acid chloride X 14 dissolved 
in 5 ml dichloromethane was added using a dropping fun-
nel during 30 minutes, stirring constantly. In the process the 
reaction solutions colour changes to yellowish. The reaction 
batch was stirred continuously over night and concentrated 
by the rotary evaporator. The yellow residue 15 featured 
oily consistency and was dissolved in dichloromethane. The 
solvent was removed by the rotary evaporator and con-
secutively purified by a silica gel column. As an eluent 
n-hexane and acetic ether were used at the ratio of 2:1. The 
purity was estimated by use of thin-layer chromatography. 
Cleavage of the tert-butyl ester. 2 mmol tert-butyl pro-
tected PNA building block functionalized with 4-pentenoic 
acid chloride was solved in 5 ml dichloromethane and 5 ml 
trifluoroacetic acid (TFA) and simultaneously 5 ml TFA 
solved in dichloromethane were added successively by a 
dropping funnel. The reaction batch was stirred conti-
nuously over night and the reaction’s completeness was 
checked by thin layer chromatography. The reaction prod-
uct was inspissated by the rotary evaporator and consecu-
tively und covered with ether. The product 16 precipitates 
voluminously, depending on the quantity the precipitation 
process can take up to two days. In this case the precipita-
tion should run at a temperature of 4°C. 
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Solid phase synthesis of the “Reppe anhydride”-PNA 
pentamer (RE-PNA)5 
In order to demonstrate the high efficiency of the 
DARinv-based “Click” chemistry and to realize ex-
periments with high local concentrations of active 
agents in cells, a pentamer of “Reppe anhydride” 
(RE-PNA)5 was synthesized exemplarily (scheme 
4/Figure 4). The instructions are documented in the 
footnote4. 
For chemical reaction by the solid phase peptide 
synthesis (SPPS) we produced a pentamer of the 
RE-PNA where an additional cysteine was attached to 
the amino terminus [(RE-PNA)5Cys = (TcT)5-Cys] 
which in turn will be coupled later to the cysteine of a 
cell membrane transport facilitating peptide (CPP), 
which permits an efficient cellular uptake imperative 
for biochemical studies.  
This (RE-PNA)5Cys acts as a cargo and repre-
sents the corresponding reaction partner, (a dieno-
phile compound) for the intracellular DARinv to func-
tionalize active substances harbouring diene reaction 
groups. The following features predispose the “Reppe 
anhydride” molecule for use in the DARinv chemis-
try.[39] To “hit two birds with one stone”, this Reppe 
anhydride PNA monomer differs from the commonly 
used PNA monomers whose nucleobase is substituted 
by the “Reppe anhydride”, harboring two independ-
ent but time dependant dienophiles with valuable 
different reactivity.  
With the two dienophiles different diene com-
ponends can be connected to the molecule important 
for experiments in cells (scheme 4/Figure 4) after 
combination with facilitating features for the passage 
across biological membranes. 
As illustrated in scheme 4/Figure 4, a cysteine is 
attached at the amino terminus of the PNA backbone 
                                                      
4 Solid phase synthesis of the “Reppe anhydride”-PNA 
pentamer. To perform the solid phase peptide synthesis 
(SPPS)[41] of PNA modules we employed the 
Fmoc-strategy[42] in a fully automated peptide synthesizer 
A433 (Perkin Elmer). The synthesis was carried out on a 0.05 
mmol Tenta Gel R Ram (Rapp Polymere) 0.19 mmol/g of 
substitution. As coupling agent 
2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hex-
afluorophosphate (HBTU) was used. A typical synthetic 
cycle consisted of a single 30 minute coupling of 3 equiva-
lents of monomer to the growing PNA chain, followed by 
capping of the unreacted free amines with acetic anhydride. 
The protected PNA resins were treated with 20% piperidine 
in dimethylformamide over 5 minutes and then washed 
thoroughly with dimethylformamide. Cleavage and depro-
tection of the resins were effected by treatment with 90% 
trifluoroacetic acid and 10% triethylsilane.  
 
for redox coupling with the cysteine of a cell pene-
trating peptide (CPP). This formulation of the conju-
gate is exemplified in scheme 5/Figure 5. 
The controlled different reactivity of the pen-
tenyl group compared to the dienophile groups in the 
Reppe anhydride allows the synthesis of PNA oli-
gomers consisting of two or more different dieno-
philes suitable for two or more independent Diels 
Alder Reactions with inverse-electron-demand 
(DARinv) as shown exemplarily in scheme 8/Figure 8. 
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Figure 8.  (Scheme  8): the scheme exemplifies the PNA 
pentamer consisting of three Reppe anhydride 5 and two 
pentenoic acid 17 building blocks; additionally a cysteine for 
disulfide coupling was included at the amino terminus. 
 
DARinv ligation of the PNA pentamer tetrazine derivat-
ized  
Scheme 9 (Figure 9) depicts the molecule after 
complete ligation by the DARinv focussed on the reac-
tion site. Details of the chemical reaction are docu-
mented by Wiessler[44]. 
Ligation of (RE-PNA)5 with di-
methyl-1,2,4,5-tetrazine-3,6-dicarboxylate 
The first dienophile, being highly reactive, al-
lows the ligation of functional molecules like carrier 
molecules on one side of the molecule. The second 
dienophile on the other side with lower reactivity is 
available for further functionalization under different 
reaction conditions e.g. as a coupling site for fluores-
cent markers.  
Ligation of (RE-PNA)5 with di-
methyl-1,2,4,5-tetrazine-3,6-dicarboxylate dansyl 
chloride connected via an ethylene diamine 
linker. 
This DARinv mediated ligation describes the re-
action product of the complete ligation of the Reppe 
anhydride pentamer (RE-PNA)5 with the di-
methyl-1,2,4,5-tetrazine-3,6-dicarboxylate functional-
ized with two dansyl chloride resulting in symmetri-
cal arrangements as illustrated in scheme 10/Figure 
10.  Int. J. Med. Sci. 2010, 7 
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Figure 9.  (Scheme  9)  shows the PNA pentamer with five functionalized Reppe anhydrides (dienophile compound) 
(RE-PNA) after ligation with dimethyl-1,2,4,5-tetrazine-3,6-dicarboxylate (diene compound). The DARinv mechanism is 
described in detail[13] and the ligation procedure is documented in the footnote.
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Figure 10. (Scheme 10) shows the ligation product of the pentamer (RE-PNA)5 molecule after the complete DARinv 
reaction with the diene compound dimethyl-1,2,4,5-tetrazine-3,6-dicarboxylate derivatized with the fluorescent marker 
dansyl chloride [5-(dimethylamino)naphthalene-1-sulfonyl chloride] connected by an ethylene diamine linker. The synthesis 
procedure is documented in the footnote.
6 
 
                                                      
5 Ligation of (RE-PNA)5 with dimethyl-1,2,4,5-tetrazine-3,6-dicarboxylate. 1.723 mg (1 µmol) of the (RE-PNA)5 pentamer 
were pre-filled and reacted with 1.089 mg (5.5 µmol) dimethyl-1,2,4,5-tetrazine-3,6-dicarboxylate dissolved in 0.5 ml dichlo-
romethane. The progress of the chemical reaction can be monitored by changes in colour. The end of the reaction is indicated 
by decolourization after a few minutes.  
 
6 Ligation of the (RE-PNA)5 with dimethyl-1,2,4,5-tetrazine-3,6-dicarboxylate dansyl chloride connected via an ethylene 
diamine linker. 1.723 mg (1 µmol) of the PNA pentamer were pre-filled and reacted with 4.807 mg of the dime-
thyl-1,2,4,5-tetrazine-3,6-dicarboxylate derivatized with dansyl as fluorescence marker (5.5 µmol) dissolved in 0.5 ml DMSO. 
After a reaction time of 10 min a brightening of the magenta stained solution was observed. To complete the chemical reac-
tion the suspension was allowed to stand over night. Int. J. Med. Sci. 2010, 7 
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Figure 11. (Scheme 11) shows the ligation product of the PNA heptamer molecule generated after two steps: the first 
ligation step (A) with the Reppe molecule as dienophile and dimethyl 1,2,4,5-tetrazine-3,6-dicarboxylate as a diene, while the 
second ligation step (B) was the reaction of the pentenoic acid group with the tetrazine functionalized twofold with dansyl 
(symmetrical molecule). To avoid sterical interactions which can hamper the ligation processes all dienophile compounds 
were spatially separated with a PNA monomer functionalized with a cyclopentane group. 
 
Table 1  lists the synthesized components which were used, other than the norbonenyl functionalized PNA building 
block, for ligation reactions. 
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Table 2  lists the compounds used as a carrier system for the DARinv ligation reaction in living cells.  
 
 
 
 
 
Ligation reaction of a PNA heptamer function-
alized with different reactive dienophiles 
This ligation uses a PNA heptamer consisting of 
dienophiles with different reactivities like the Reppe 
anhydride and the pentenoic acid. In turn, these are 
separated by a cyclopentane building block avoiding 
possible steric interactions which could restrict the 
ligation efficiency. The ligation begins with chemical 
reaction of the Reppe anhydrides cyclobutene, the 
dienophile with the highest reactivity. After the reac-
tion was complete, the second ligation reaction with 
the pentenoic acid was started. The sequenced liga-
tion reactions A and B are described detailed in the 
footnote.7 
                                                       
7 A. 2,005 mg (1 µmol) of the PNA heptamer were pre-filled 
and reacted with 0.396 mg (1.0 µmol) of dimethyl 
1,2,4,5-tetrazine-3,6-dicarboxylate dissolved in 0.5 ml dich-
loromethane under stirring. The reaction vessel was al-
lowed to stand until decolorization was complete after circa 
10 min. B. In a second step 0.874 mg of the tetrazine deri-
vatized twofold with dansyl, was dissolved in a few drops 
of DMSO and then added to the reaction product of A. The 
Discussion 
Here we demonstrate the synthesis of exemplary 
PNA building blocks suitable for a broad spectrum of 
ligation reactions as listed in table 1 for which the 
DARinv is predestined. For future applications the 
rapid and selective ligation must also bear dedicated 
requirements e.g. in living systems stable educts, in-
termediates, and products respectively. To meet these 
demands the PNA can be considered as a promising 
candidate: As demonstrated by its chemical structure, 
it resembles neither a peptide nor a nucleic acid, 
which results in a stability against enzymatic degra-
dation by peptidases and nucleases. For this case, 
these properties justify the development of PNA 
based molecules with completely new functions ap-
propriate for ligation reactions in the “Click chemis-
                                                                                        
reaction mixture was shaken and then allowed to settle over 
night. 
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try”, instead of using conventional PNA harboring 
nucleobases. The multifaceted spectrum of applica-
tions of Click Chemistry is comprehensively detailed 
in the Volume 39, Issue 4 of the ChemSocRev in 2010. 
Our new molecules could be functionalized, as 
diene-, or dienophile-compounds by coupling to the 
glycine’s N-terminus which in turn is linked to an 
ethylendiamine N-monosubstituted Fmoc. In this 
manuscript we used the Tetracy-
clo-[5.4.21,7.O2,6.O8,11]3,5-dioxo-4-aza-9,12-tridecadiene
, well known as “Reppe anhydride”, moderately de-
rivatized for coupling at the PNA backbone, repre-
senting a suitable dienophile-compound candidate 11 
(RE-PNA). Its chemical reactions, as well as the cor-
responding multi-faced range, are comprehensively 
documented.[45] We focused our studies on the 
RE-PNA pentamer. It is also important to note that the 
use of the Fmoc-protected PNA-monomer derivatives 
like RE-PNA avoids both, an unnecessary expansion 
of the molecule after ligation, and also associated 
undesired reactions and steric effects. Using the ex-
ample of the RE-PNA monomer, the functionalized 
PNA monomers should be considered as candidates 
for powerful molecules which allow rapid and com-
plete ligation reactions in aqueous solution, at room 
temperature and without catalytic support. Further-
more, using these functionalized PNA monomers like 
Fmoc-protected RE-PNA the PNA synthesis itself can 
be carried out by automated conventional solid phase 
peptide synthesis, which avoids unnecessary cou-
pling steps and results in high yields and quality. Also 
in future pharmacological applications, as yet im-
practicable, this example could establish a platform 
for expanded use in the PNA, the DNA and the RNA 
world.  
Conclusion 
Here we like to emphasize the simple rationale 
of click chemistry for a use in medical applications. 
We describe the synthesis of complex functional 
molecules made by simple methods like the solid 
phase synthesis using the functionalized monomers. 
The “Click chemistry” demands not expansive 
educts but proper products for the irreversible 
DARinvers ligation chemistry. This chemical reaction 
produces solely nitrogen as a by-product. 
Efficient Click chemistry does not depend of 
stringent reaction conditions, takes place preferen-
tially in aqueous solutions and is therefore useful for 
reaction in living cells.  
With the functionalization of PNA building 
blocks and oligomer synthesis we can realize high 
local concentrations of diagnostic or/and therapeutic 
molecules at the desired target site. 
Acknowledgements 
This work was supported in part by grant from 
the Deutsche Krebshilfe Foundation (Project No. 
106335).  
Conflict of Interest 
The authors have declared that no conflict of in-
terest exists. 
References 
1.  Miller SL. Peptide nucleic acids and prebiotic chemistry. Nat 
Struct Biol. 1997; 4: 167-9. 
2.  Nielsen PE. Peptide nucleic acids and the origin of life. Chem 
Biodivers. 2007; 4: 1996-2002. 
3.  Nielsen PE, Egholm M, Berg RH, et al. Sequence-selective 
recognition of DNA by strand displacement with a 
thymine-substituted polyamide. Science. 1991; 254: 1497-500. 
4.  Huisgen R. Theory of 1,3-Dipolar Cycloadditions. In: Padwa A, 
editor. 1,3-Dipolar Cycloaddition Chemistry. New York: Wiley; 
1984: 1-176. 
5.  Lin FL, Hoyt HM, van HH, et al. Mechanistic investigation of 
the staudinger ligation. J Am Chem Soc. 2005; 127: 2686-95. 
6.  Seelig B, Jaschke A. Site-specific modification of enzymatically 
synthesized RNA: Transcription initiation and Diels-Alder 
reaction. Tetrahedron Letters. 1997; 38: 7729-32. 
7.  Kolb HC, Finn MG, Sharpless KB. Click Chemistry: Diverse 
Chemical Function from a Few Good Reactions. Angew Chem 
Int Ed Engl. 2001; 40: 2004-21. 
8.  Finn MG, Fokin VV. Click chemistry: function follows form. 
Chem Soc Rev. 2010; 39: 1231-2. 
9.  Bachmann WE, Chemerda JM. The Diels Alder Reaction of 
1-Vinyl-6-Methoxy-3,4-Dihydronaphthalene with Citraconic 
Anhydride. J Americ Chem Soc. 1948; 70: 1468-73. 
10. Alder K, Diels O. [Otto Diels and Kurt Alder; winners of the 
Nobel Prize in chemistry.]. Cienc Invest. 1951; 7: 143-4. 
11.  Stocking EM, Williams RM. Chemistry and biology of 
biosynthetic Diels-Alder reactions. Angew Chem Int Ed Engl. 
2003; 42: 3078-115. 
12. Blackman ML, Royzen M, Fox JM. Tetrazine ligation: fast 
bioconjugation based on inverse-electron-demand Diels-Alder 
reactivity. J Am Chem Soc. 2008; 130: 13518-9. 
13. Waldeck W, Wiessler M, Ehemann V, et al. TMZ-BioShuttle--a 
reformulated temozolomide. Int J Med Sci. 2008; 5: 273-84. 
14. Ibrahim-Ouali M. Diels-Alder route to steroids and associated 
structures. Steroids. 2009 Feb;74(2):133-62. 
15.  Carboni RA, Lindsey RV. Reactions of Tetrazines with 
Unsaturated Compounds - A New Synthesis of Pyridazines. J 
Americ Chem So. 1959; 81: 4342-6. 
16.  Nielsen PE, Egholm M. An introduction to peptide nucleic acid. 
Curr Issues Mol Biol. 1999; 1: 89-104. 
17. Nielsen PE, Egholm M, Berg RH, et al. Peptide nucleic acids 
(PNAs): potential antisense and anti-gene agents. Anticancer 
Drug Des. 1993; 8: 53-63. 
18.  Corey DR. Peptide nucleic acids: expanding the scope of nucleic 
acid recognition. Trends Biotechnol. 1997; 15: 224-9. 
19. Stein CA, Subasinghe C, Shinozuka K, et al. Physicochemical 
properties of phosphorothioate oligodeoxynucleotides. Nucleic 
Acids Res. 1988; 16: 3209-21. 
20. Johansson HE, Belsham GJ, Sproat BS, et al. Target-specific 
arrest of mRNA translation by antisense 
2'-O-alkyloligoribonucleotides. Nucleic Acids Res. 1994; 22: 
4591-8. Int. J. Med. Sci. 2010, 7 
 
http://www.medsci.org 
223
21.  Heidenreich O, Gryaznov S, Nerenberg M. RNase 
H-independent antisense activity of oligonucleotide N3 '-- > P5 ' 
phosphoramidates. Nucleic Acids Res. 1997; 25: 776-80. 
22. Egholm M, Nielsen PE, Buchardt O, et al. Recognition of 
Guanine and Adenine in DNA by Cytosine and Thymine 
Containing Peptide Nucleic-Acids (PNA)(1,2). J AMER CHEM 
SOC. 1992; 114: 9677-8. 
23. Summerton J, Weller D. Morpholino antisense oligomers: 
design, preparation, and properties. Antisense Nucleic Acid 
Drug Dev. 1997; 7: 187-95. 
24. Koshkin AA, Nielsen P, Meldgaard M, et al. LNA (locked 
nucleic acid): An RNA mimic forming exceedingly stable LNA : 
LNA duplexes. Journal of the American Chemical Society. 1998; 
120: 13252-3. 
25. Nielsen PE. Peptide Nucleic-Acid (PNA) a Structural DNA 
Mimic. PROG BIOPHYS MOL BIOL. 1996; 65: 103. 
26. Demidov VV, Potaman VN, Frank Kamenetskii MD, et al. 
Stability of peptide nucleic acids in human serum and cellular 
extracts. Biochem Pharmacol. 1994; 48: 1310-3. 
27.  Egholm M, Buchardt O, Nielsen PE, et al. Peptide Nucleic Acids 
(PNA). Oligonucleotide Analogues with an Achiral Peptide 
Backbone. J Am Chem Soc. 1992; 114: 1895-7. 
28. Braun K, von Brasch L, Pipkorn R, et al. BioShuttle-mediated 
plasmid transfer. Int J Med Sci. 2007; 4: 267-77. 
29. Nielsen PE. Applications of peptide nucleic acids. Curr Opin 
Biotechnol. 1999; 10: 71-5. 
30.  Mah C, Byrne BJ, Flotte TR. Virus-based gene delivery systems. 
Clin Pharmacokinet. 2002; 41: 901-11. 
31.  Mahato RI. Non-viral peptide-based approaches to gene 
delivery. J Drug Target. 1999; 7: 249-68. 
32. Filipovska  A,  Eccles MR, Smith RAJ, et al. Delivery of antisense 
peptide nucleic acids (PNAs) to the cytosol by disulphide 
conjugation to a lipophilic cation. Febs Letters. 2004; 556: 180-6. 
33.  Gait MJ. Peptide-mediated cellular delivery of antisense 
oligonucleotides and their analogues. Cell Mol Life Sci. 2003; 
60: 844-53. 
34.  Wagner E. Effects of membrane-active agents in gene delivery. J 
Controlled Release. 1998; 53: 155-8. 
35.  Ardhammar M, Norden B, Nielsen PE, et al. In vitro membrane 
penetration of modified peptide nucleic acid (PNA). J Biomol 
Struct Dyn. 1999; 17: 33-40. 
36. Koppelhus U, Nielsen PE. Cellular delivery of peptide nucleic 
acid (PNA). Adv Drug Deliv Rev. 2003; 55: 267-80. 
37.  Braun K, Pipkorn R, Waldeck W. Development and 
Characterization of Drug Delivery systems for Targeting 
Mammalian Cells and Tissues: A Review. Curr Med Chem. 
2005; 12: 1841-58. 
38. Thomson SA, Josey JA, Cadilla R, et al. Fmoc Mediated 
Synthesis of Peptide Nucleic-Acids. TETRAHEDRON. 1995; 51: 
6179-94. 
39.  Reppe W, Schlichting O, Klager K, et al. Cyclisierende 
Polymerisation von Acetylen I. Justus Liebigs Annalen der 
Chemie. 1948; 560: 1-92. 
40. Atherton E, Sheppard RC. In: Undenfriend S, Meienhofer J, 
editors. The Peptides. Orlando: Academic Press; 1987: 1-38. 
41. Merriefield RB. Solid Phase Peptide Synthesis. I The Synthesis 
of a Tetrapeptide. J Americ Chem Soc. 1963; 85: 2149-54. 
42.  Carpino LA, Han GY. The 9-Fluorenylmethoxycarbonyl 
Amino-Protecting Group. J ORG CHEM. 1972; 37: 3404-9. 
43. Braun K, Peschke P, Pipkorn R, et al. A biological transporter 
for the delivery of peptide nucleic acids (PNAs) to the nuclear 
compartment of living cells. J Mol Biol. 2002; 318: 237-43. 
44.  Wiessler M, Waldeck W, Kliem C, et al. The 
Diels-Alder-reaction with inverse-electron-demand, a very 
efficient versatile click-reaction concept for proper ligation of 
variable molecular partners. Int J Med Sci. 2009; 7: 19-28. 
45.  Pipkorn R, Waldeck W, Didinger B, et al. 
Inverse-electron-demand Diels-Alder reaction as a highly 
efficient chemoselective ligation procedure: Synthesis and 
function of a BioShuttle for temozolomide transport into 
prostate cancer cells. J Pept Sci. 2009; 15: 235-41. 
 